T1	Participants 66 82	type 2 diabetes:
T2	Participants 572 596	type 2 diabetes subjects
T3	Participants 879 924	8 patients, 5 of whom were insulin-requiring.
T4	Participants 1516 1537	type 2 diabetes group
T5	Participants 1767 1794	normal nondiabetic subjects
